Acta Med. 2008, 51: 121-126
https://doi.org/10.14712/18059694.2017.13
Issues and Ethical Problems of Stem Cell Therapy – Where is Hippocrates?
References
1. M. The debate surrounding human embryonic stem cell research in the USA. Reprod Biomed Online 2007; 15:7–11.
<https://doi.org/10.1016/S1472-6483(10)60544-5>
2. GJ and Elias S. Politics, morals and embryos. Nature 2004; 431:19–20.
<https://doi.org/10.1038/431019a>
3. H, Schill KE, Faden RR. Justice, ethnicity, and stem-cell banks. Lancet 2004; 364:118–121.
<https://doi.org/10.1016/S0140-6736(04)16650-6>
4. S. The context of embryonic development and its ethical relevance. Biotechnol J 2007; 2:1147–1153.
<https://doi.org/10.1002/biot.200700096>
5. DL, Johansson CB, Frisén J, et al. Generalized potential of adult neural stem cells. Science 2000, 288:1660–1663.
<https://doi.org/10.1126/science.288.5471.1660>
6. CB. Stem cell research in the U.S. after the President’s speech of August 2001. Kennedy Inst Ethics J 2004; 1:97–114.
<https://doi.org/10.1353/ken.2004.0012>
7. Committee on culture, science and education, Paliamentary Assembly of the Council of Europe. Human Reprod Genet Ethics 2004; 10:53–67.
8. HW. Human embryonic stem cells: the real challenge for research as well as for bioethics is still ahead of us. Cells Tissues Organs 2008; 187:250–256.
<https://doi.org/10.1159/000116612>
9. K. What’s in a name? Embryos, entities, and antities in the stem cell debate. J Med Ethics 2006; 32:43–48.
<https://doi.org/10.1136/jme.2005.012203>
<PubMed>
10. G and Mummery Ch. Human embryonic stem cells: research, ethics and policy. Human Reprod 2003; 18:672–682.
11. RM. The problem of deception in embryonic stem cell research. Cell Prolif 2008; 41:65–70.
<https://doi.org/10.1111/j.1365-2184.2008.00492.x>
<PubMed>
12. M, Pedersen BD. Using empirical research to formulate normative ethical principles in biomedicine. Med Health Care Philos 2007; 10:33–48.
<https://doi.org/10.1007/s11019-006-9011-9>
13. V and Sommerville A. Presumed concept for transplantation: a dead issue after Alder Hey? J Med Ethics 2003; 29:147–152.
<https://doi.org/10.1136/jme.29.3.147>
<PubMed>
14. S, Mokrý J, English D, Vojáček J. Stem cell plasticity and issues of stem cell therapy. Folia Biologica (Prague) 2005; 51:180–187.
15. S, Mokrý J, Hruška I. Adult stem cells and their importance in cell therapy. Folia Biologica (Prague) 2003; 49:9–14.
16. S, English D, Mokrý J. Issues in stem cell plasticity. J Cell Mol Med 2004; 8:572–577.
<https://doi.org/10.1111/j.1582-4934.2004.tb00483.x>
<PubMed>
17. S, Mokrý J, English D, Vojáček J. Stem cell plasticity and issues of stem cell therapy. Folia Biologica (Prague) 2005; 51:180–187.
18. GD and Fischbach RL. Stem cells: science, policy, and ethics. J Clin Invest 2004; 114:1364–1370.
<https://doi.org/10.1172/JCI200423549>
19. SS. A lot of the problem we have in trying to develop these technologies for medicine is people’s knee-jerk reaction to words like fetal and embryo. The New York Times Magazine. January, 2000; 30:32–35.
20. M, Bower C, Milne E, et al. Assisted reproductive technologies and the risk of birth defects a systematic review. Hum Reprod 2004; 26:127–133.
21. WB. Ethics and embryonic stem cell research: altered nuclear transfer as a way forward. BioDrugs 2007; 21:79–83.
<https://doi.org/10.2165/00063030-200721020-00002>
22. R. Human cloning – the science and ethics of nuclear transplantation. N Engl J Med 2004; 351:2787–2791.
<https://doi.org/10.1056/NEJMp048304>
23. N. Stem cell research: an ethical evaluation of policy opinions. Kennedy Inst, Ethics J 2004; 1:55–74.
<https://doi.org/10.1353/ken.2004.0018>
24. R and Green RM. Bush’s policy stopped US gaining stem-cell lead. Nature 2005; 438:422.
<https://doi.org/10.1038/438422a>
25. CG, Moore H, Ruban L, et al. Human embryonic stem cells: possibilities for human cell transplantation. Ann Med 2005; 37:521–532.
<https://doi.org/10.1080/07853890500379463>
26. A and Newman SA. The ethics of deriving gamets from ES cells. Science 2005; 307:515–51.
<https://doi.org/10.1126/science.307.5709.515c>
27. R. Ethical and legal issues in therapeutic cloning and the study stem cells. Arch Med 2003; 34:607–611.
28. E. Ethicists back stem cells research, White house trends cautiously. Science 1999; 285:502.
<https://doi.org/10.1126/science.285.5427.502a>
29. E. The business of stem cells. Science 2000; 287:1419–1421.
<https://doi.org/10.1126/science.287.5457.1419>
30. , A. Stem Cells: Golden opportunities with ethical baggage. Science 2000; 288:1778.
<https://doi.org/10.1126/science.288.5472.1778>
31. SJ. It’s not just theologians who are morally troubled. Nature 2005; 433:355.
<https://doi.org/10.1038/433355c>
32. DW. Bioethics, science, and politics. N Engl J Med 2004; 351:298–300.
33. R. The legal status of the human embryo. Reprod Biomed Online 2007; 14:54–60.
<https://doi.org/10.1016/S1472-6483(10)60728-6>
34. D. Stem cells: the ethical problems of using embryos for research. J Contemp Health Law Policy 2006; 22:439–447.
35. J, Karbanova J, Filip S. Differentiation potential of murine neural stem cells in vitro after transplantation. Transplant Proc 2005; 37:268–272.
<https://doi.org/10.1016/j.transproceed.2004.12.233>
36. A. From the atom to the cell: is the cat alive? Quantum mechanics and stem cell plasticity as déja vu. Stem Cells Dev 2006; 15:488–491.
37. DC, Bock TA, Kanz L. Hemopoietic stem cells: Biology and transplantation. Ann N Y Acad Sci 1999; 872:405.
38. C. Ethics for embryos. J Med Ethics 2007; 33:614–616.
<https://doi.org/10.1136/jme.2006.018986>
<PubMed>
39. K. Arguments for human therapeutic cloning. Bosn J Basic Med Sci 2004; 4:15–18.
<https://doi.org/10.17305/bjbms.2004.3454>
<PubMed>
40. MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143–147.
<https://doi.org/10.1126/science.284.5411.143>
41. Y. Diffusion and reaction-diffusion in fast cellular flows. Chaos 2004; 14:903–909.
<https://doi.org/10.1063/1.1772191>
42. , A.J. and Chudley, A.E. Stem cell research: cloning, therapy and scientific found. Clin Genet 2006; 70:302–305.
<https://doi.org/10.1111/j.1399-0004.2006.00678.x>
43. MJ. Embryo ethics-the moral logic of stem-cell research. N Engl J Med 2004; 35:207–209.
44. M and Verfaillie CM. Pluripotency in adult stem cells of the art. Semin Reprod Med 2006; 24:379–388.
<https://doi.org/10.1055/s-2006-952153>
45. JL. The importance of valid disclosures in the human embryonic stem cell research debate. Cell Prolif 2008; 41:57–64.
<https://doi.org/10.1111/j.1365-2184.2008.00483.x>
<PubMed>
46. D. The business of stem cells. N Engl J Med 2004; 351:211–213.
<https://doi.org/10.1056/NEJMp048138>
47. A, Zeiser R, Follo M, Metaxas Y, Finke, J. Stem cell plasticity: the debate begins to clarify. Stem Cell Rev 2005; 1:37–43.
<https://doi.org/10.1385/SCR:1:1:037>
48. FW. Historical and philosophical perspectives on experimental practice in medicine and the life sciences. Theor Med Bioeth 2005; 26:397–425.
<https://doi.org/10.1007/s11017-005-1425-5>
49. G and Harris J. Genetics. Ethical aspects of ES cell-derived gametes. Science 2004; 30:1719.
<https://doi.org/10.1126/science.1103083>
50. , J.A., Itskovitz-Eldor, J., Shapiro, S.S., et al. Embryonic stem cells lines derived from human blastocyts. Science 1998; 282:1145–1147.
<https://doi.org/10.1126/science.282.5391.1145>
51. CR and Jones DG. Stem cells embryos, and the environment: a context for both science and ethics. J Med Ethics 2004; 30:410–413. Hum Reprod 2004;26:127–133.
<https://doi.org/10.1136/jme.2003.002386>
<PubMed>
52. AO. Future and application of cloning. Methods Mol Biol 2006; 348:319–332.
<https://doi.org/10.1007/978-1-59745-154-3_22>
53. D and Weiss S. Why stem cells? Science 2000; 287:1439–1441.
<https://doi.org/10.1126/science.287.5457.1439>
